Trial intelligence / Profile preview

hUC-MSCs for Decompensated Liver Cirrhosis

NCT01342250Phase 2Completed

Sponsor
Beike Biotechnology
Start
Oct 2010
Primary completion
Jul 2011
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of human umbilical cord mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Beike Biotechnology. Started Oct 2010; status: completed.

02

Drugs

human umbilical cord mesenchymal stem cells
03

Conditions

Liver cirrhosis (LC)

Beyond the preview

Go deeper on NCT01342250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01342250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call